Caveolin-1 Mediates Inflammatory Breast Cancer Cell Invasion via the Akt1 Pathway and RhoC GTPase

被引:35
作者
Joglekar, Madhura [1 ,2 ]
Elbazanti, Weam O. [1 ,2 ]
Weitzman, Matthew D. [1 ,2 ]
Lehman, Heather L. [1 ,2 ]
van Golen, Kenneth L. [1 ,2 ]
机构
[1] Univ Delaware, Ctr Translat Canc Res, Dept Biol Sci, Newark, DE 19716 USA
[2] Helen F Graham Canc Ctr, Newark, DE USA
关键词
RhoC GTPase; CAVEOLIN-1; INFLAMMATORY BREAST CANCER; INVASION; METASTASIS; IN-VITRO; METASTASIS; PROTEIN; GROWTH; EXPRESSION; PHENOTYPE; MOTILITY; TUMOR; PHOSPHORYLATION; OVEREXPRESSION;
D O I
10.1002/jcb.25025
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
With a propensity to invade the dermal lymphatic vessels of the skin overlying the breast and readily metastasize, inflammatory breast cancer (IBC) is arguably the deadliest form of breast cancer. We previously reported that caveolin-1 is overexpressed in IBC and that RhoC GTPase is a metastatic switch responsible for the invasive phenotype. RhoC-driven invasion requires phosphorylation by Akt1. Using a reliable IBC cell line we set out to determine if caveolin-1 expression affects RhoC-mediated IBC invasion. Caveolin-1 was down regulated by introduction of siRNA or a caveolin scaffolding domain. The ability of the cells to invade was tested and the status of Akt1 and RhoC GTPase examined. IBC cell invasion is significantly decreased when caveolin-1 is down regulated. Activation of Akt1 is decreased when caveolin-1 is down regulated, leading to decreased phosphorylation of RhoC GTPase. Thus, we report here that caveolin-1 overexpression mediates IBC cell invasion through activation Akt1, which phosphorylates RhoC GTPase. (C) 2015 Wiley Periodicals, Inc.
引用
收藏
页码:923 / 933
页数:11
相关论文
共 47 条
[1]
Breast cancer nodal metastasis correlates with tumour and lymph node methylation profiles of Caveolin-1 and CXCR4 [J].
Alevizos, Leonidas ;
Kataki, Agapi ;
Derventzi, Anastasia ;
Gomatos, Ilias ;
Loutraris, Christos ;
Gloustianou, Georgia ;
Manouras, Andreas ;
Konstadoulakis, Manousos M. ;
Zografos, George .
CLINICAL & EXPERIMENTAL METASTASIS, 2014, 31 (05) :511-520
[2]
The interaction between caveolin-1 and Rho-GTPases promotes metastasis by controlling the expression of alpha5-integrin and the activation of Src, Ras and Erk [J].
Arpaia, E. ;
Blaser, H. ;
Quintela-Fandino, M. ;
Duncan, G. ;
Leong, H. S. ;
Ablack, A. ;
Nambiar, S. C. ;
Lind, E. F. ;
Silvester, J. ;
Fleming, C. K. ;
Rufini, A. ;
Tusche, M. W. ;
Bruestle, A. ;
Ohashi, P. S. ;
Lewis, J. D. ;
Mak, T. W. .
ONCOGENE, 2012, 31 (07) :884-896
[3]
Markers of breast cancer stromal fibroblasts in the primary tumour site associated with lymph node metastasis: a systematic review including our case series [J].
Azevedo Koike Folgueira, Maria Aparecida ;
Maistro, Simone ;
Hirata Katayama, Maria Lucia ;
Roela, Rosimeire Aparecida ;
Lopes Mundim, Fiorita Gonzales ;
Nanogaki, Suely ;
de Bock, Geertruida H. ;
Brentani, M. Mitzi .
BIOSCIENCE REPORTS, 2013, 33 :921-929
[4]
Statin use in primary inflammatory breast cancer: a cohort study [J].
Brewer, T. M. ;
Masuda, H. ;
Liu, D. D. ;
Shen, Y. ;
Liu, P. ;
Iwamoto, T. ;
Kai, K. ;
Barnett, C. M. ;
Woodward, W. A. ;
Reuben, J. M. ;
Yang, P. ;
Hortobagyi, G. N. ;
Ueno, N. T. .
BRITISH JOURNAL OF CANCER, 2013, 109 (02) :318-324
[5]
Hsp90 and caveolin are key targets for the proangiogenic nitric oxide-mediated effects of statins [J].
Brouet, A ;
Sonveaux, P ;
Dessy, C ;
Moniotte, S ;
Balligand, JL ;
Feron, O .
CIRCULATION RESEARCH, 2001, 89 (10) :866-873
[6]
Farnesyl transferase inhibitor treatment of breast cancer cells leads to altered RhoA and RhoC GTPase activity and induces a dormant phenotype [J].
Chatterjee, Moumita ;
van Golen, Kenneth L. .
INTERNATIONAL JOURNAL OF CANCER, 2011, 129 (01) :61-69
[7]
Genomic analysis of metastasis reveals an essential role for RhoC [J].
Clark, EA ;
Golub, TR ;
Lander, ES ;
Hynes, RO .
NATURE, 2000, 406 (6795) :532-535
[8]
Davies S., 1998, Proceedings of the American Association for Cancer Research Annual Meeting, V39, P94
[9]
X-ray crystal structures reveal two activated states for RhoC [J].
Dias, Sandra M. G. ;
Cerione, Richard A. .
BIOCHEMISTRY, 2007, 46 (22) :6547-6558
[10]
Caveolin 1 and caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype [J].
Elsheikh, S. E. ;
Green, A. R. ;
Rakha, E. A. ;
Samaka, R. M. ;
Ammar, A. A. ;
Powe, D. ;
Reis-Filho, J. S. ;
Ellis, I. O. .
BRITISH JOURNAL OF CANCER, 2008, 99 (02) :327-334